The expansion includes noninvasive, vital sign measuring devices that measure body temperature, respiratory rate, heart rate and blood pressure.
“Allowing these devices to be used remotely can help healthcare providers access information about a patient’s vital signs while the patient is at home, reducing the need for hospital visits and minimizing the risk of exposure to coronavirus,” said FDA Principal Deputy Commissioner Amy Abernethy, MD, according to the news release.
The policy, which is limited to the duration of the coronavirus emergency, applies to certain modifications to claims, functionality, hardware or software of FDA-cleared remote patient monitoring devices.
More articles on telehealth:
CMS launches telehealth toolkits to navigate new regulations: 3 things to know
How the coronavirus pandemic is impacting mental telehealth services
AMA, Physicians Foundation, state medical associations launch telehealth initiative amid coronavirus pandemic
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.